Neihulizumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Neihulizumab, covering 2016-04-25 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD) [Phase 1]